NO165635C - Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater.

Info

Publication number
NO165635C
NO165635C NO862230A NO862230A NO165635C NO 165635 C NO165635 C NO 165635C NO 862230 A NO862230 A NO 862230A NO 862230 A NO862230 A NO 862230A NO 165635 C NO165635 C NO 165635C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
quinoline derivatives
new therapeutically
analogy procedure
Prior art date
Application number
NO862230A
Other languages
English (en)
Norwegian (no)
Other versions
NO862230L (no
NO165635B (no
NO862230D0 (no
Inventor
Edit Berenyi
Laszlo Varga
Laszlo Pallos
Lujza Petoecz
Laszlo Ladanyi
Peter Toempe
Eva Hartai
Agnes Kovacs
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO862230D0 publication Critical patent/NO862230D0/no
Publication of NO862230L publication Critical patent/NO862230L/no
Publication of NO165635B publication Critical patent/NO165635B/no
Publication of NO165635C publication Critical patent/NO165635C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
NO862230A 1985-06-04 1986-06-04 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater. NO165635C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852193A HU195487B (en) 1985-06-04 1985-06-04 Process for producing quinoline derivatives

Publications (4)

Publication Number Publication Date
NO862230D0 NO862230D0 (no) 1986-06-04
NO862230L NO862230L (no) 1986-12-05
NO165635B NO165635B (no) 1990-12-03
NO165635C true NO165635C (no) 1991-03-13

Family

ID=10958222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862230A NO165635C (no) 1985-06-04 1986-06-04 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater.

Country Status (28)

Country Link
US (1) US4652562A (sv)
JP (1) JPS6248668A (sv)
KR (1) KR930006775B1 (sv)
CN (1) CN1012957B (sv)
AT (1) AT392469B (sv)
AU (1) AU588883B2 (sv)
BE (1) BE904864A (sv)
CA (1) CA1266650A (sv)
CH (1) CH668069A5 (sv)
CS (1) CS257793B2 (sv)
DD (1) DD247448A5 (sv)
DE (1) DE3618724C2 (sv)
DK (1) DK162841C (sv)
ES (1) ES8707231A1 (sv)
FI (1) FI82451C (sv)
FR (1) FR2582835B1 (sv)
GB (1) GB2176185B (sv)
GR (1) GR861452B (sv)
HU (1) HU195487B (sv)
IL (1) IL79024A0 (sv)
IT (1) IT1204377B (sv)
NL (1) NL8601434A (sv)
NO (1) NO165635C (sv)
PH (1) PH24135A (sv)
PL (1) PL146498B1 (sv)
PT (1) PT82712B (sv)
SE (1) SE466308B (sv)
SU (1) SU1398773A3 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
DE60119939T2 (de) * 2000-09-21 2006-11-30 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielle mittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165520B (sv) * 1972-05-05 1974-09-28
IE47458B1 (en) * 1977-11-07 1984-03-21 Leo Pharm Prod Ltd Quinolylguanidine derivatives

Also Published As

Publication number Publication date
CN1012957B (zh) 1991-06-26
KR870000324A (ko) 1987-02-17
IL79024A0 (en) 1986-09-30
SE8602524L (sv) 1986-12-05
SE8602524D0 (sv) 1986-06-04
FI82451B (fi) 1990-11-30
AU588883B2 (en) 1989-09-28
FR2582835A1 (fr) 1986-12-05
BE904864A (fr) 1986-12-03
HU195487B (en) 1988-05-30
NO862230L (no) 1986-12-05
DE3618724C2 (de) 1994-06-16
CS257793B2 (en) 1988-06-15
CN86103688A (zh) 1987-02-11
ES555708A0 (es) 1987-07-16
GB2176185A (en) 1986-12-17
AT392469B (de) 1991-04-10
NL8601434A (nl) 1987-01-02
GR861452B (en) 1986-10-03
GB8613530D0 (en) 1986-07-09
DE3618724A1 (de) 1987-01-08
NO165635B (no) 1990-12-03
AU5834486A (en) 1986-12-11
JPH0515705B2 (sv) 1993-03-02
JPS6248668A (ja) 1987-03-03
DK262186A (da) 1986-12-05
GB2176185B (en) 1988-09-28
FI862381A (fi) 1986-12-05
ATA149286A (de) 1990-09-15
US4652562A (en) 1987-03-24
PT82712A (en) 1986-07-01
ES8707231A1 (es) 1987-07-16
PT82712B (pt) 1988-04-21
PH24135A (en) 1990-03-05
FR2582835B1 (fr) 1989-01-06
CH668069A5 (de) 1988-11-30
DK162841C (da) 1992-05-04
DK262186D0 (da) 1986-06-04
FI862381A0 (fi) 1986-06-04
KR930006775B1 (ko) 1993-07-23
NO862230D0 (no) 1986-06-04
DD247448A5 (de) 1987-07-08
CA1266650A (en) 1990-03-13
HUT41008A (en) 1987-03-30
PL146498B1 (en) 1989-02-28
IT8620667A0 (it) 1986-06-04
FI82451C (sv) 1991-03-11
SE466308B (sv) 1992-01-27
SU1398773A3 (ru) 1988-05-23
DK162841B (da) 1991-12-16
IT1204377B (it) 1989-03-01

Similar Documents

Publication Publication Date Title
NO171638C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO871727D0 (no) Fremgangsmaate for fremstilling av nye kinolinderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO161370C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridin-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO159446C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO163816C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive piperazinderivater.
NO871879D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO162721C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater.
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO821904L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO165679C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere.
NO891024D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive kinolin- og acridinforbindelser.
NO165635C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater.